Patent · US Active

Hepatitis C virus inhibitors

US10787441B2 · kind B2 · utility

0Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 17, 2017
Grant dateSep 29, 2020
Priority date—
Expiry dateApr 17, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula (I) or (II), for treating or preventing an HCV infection in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.